Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy
A major reason for the failure of the immune system to detect tumor antigens (TAs) is the insufficient uptake, processing, and presentation of TAs by antigen-presenting cells (APCs). The immunogenicity of TAs in the individual patient can be markedly increased by the in situ targeting of tumor cells...
Saved in:
Main Author: | Uri Galili (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Generation of αGal-enhanced bifunctional tumor vaccine
by: Jian He, et al.
Published: (2022) -
Immunotherapy in Pediatric Solid Tumors
by: Jung Yoon Choi
Published: (2020) -
Recent updates on Sintilimab in solid tumor immunotherapy
by: Xuhong Liu, et al.
Published: (2020) -
Advances in Polymeric Micelles: Responsive and Targeting Approaches for Cancer Immunotherapy in the Tumor Microenvironment
by: Lichun Cheng, et al.
Published: (2023) -
Dendritic Cell-based Immunotherapy in Solid and Haematologic Tumors
Published: (2020)